SMMT
SMMT
NASDAQ · Biotechnology

Summit Therapeutics Inc

Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks
$18.08
+0.93 (+5.42%)
As of May 9, 9:32 PM ET ·
Analyst Consensus
Buy
23
Analysts
High
Coverage
Buy 17 74%
Hold 5 22%
Sell 1 4%
Price Target
Analyst Price Target +984.5% upside
Low Target $141.53
Average Target $196.08
High Target $244.39
Current Price $18.08
Current
$18.08
Target
$196.08
$141.53 $196.08 avg $244.39
Scenario Analysis
Bear Case
$141.53
682.8%
Low target
Base Case
$196.08
+984.5%
Avg target
Bull Case
$244.39
+1,251.7%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$30.98
-41.6% from high
52-Week Low
$13.83
+30.7% from low
50-Day SMA
$16.75
+7.9% vs SMA
200-Day SMA
$20.83
-13.2% vs SMA
RSI (14)
54.0
Neutral
Target vs 52W High
$196.08
+532.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 28 96% $143.40 +41.5%